Skip to content
type1.science
Phase 3Active, not recruitingNCT01897688

Single-center phase 3 islet transplantation in non-uremic T1D

Northwestern phase 3 donor-islet transplant study for non-uremic people with difficult T1D control.

Primary endpoints

  • To demonstrate the safety and efficacy of islet transplantation under alemtuzumab induction for treatment of Type-1 Diabetes (T1D) in subjects with hypoglycemia unawareness and a history of severe hypoglycemic episodes.

Results so far

No results posted yet.